![](/img/cover-not-exists.png)
Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI
Okuma, Yusuke, Hosomi, YukioVolume:
9
Language:
english
Journal:
Journal of Thoracic Disease
DOI:
10.21037/jtd.2017.03.26
Date:
March, 2017
File:
PDF, 101 KB
english, 2017